These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 24902645)
1. Effect of subcutaneous injection of botulinum toxin A on spinal cord injury-associated neuropathic pain. Han ZA; Song DH; Chung ME Spinal Cord; 2014 Jun; 52 Suppl 1():S5-6. PubMed ID: 24902645 [TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury. Han ZA; Song DH; Oh HM; Chung ME Ann Neurol; 2016 Apr; 79(4):569-78. PubMed ID: 26814620 [TBL] [Abstract][Full Text] [Related]
4. Use of botulinum toxin type A injection for neuropathic pain after trigeminal nerve injury. Yoon SH; Merrill RL; Choi JH; Kim ST Pain Med; 2010 Apr; 11(4):630-2. PubMed ID: 20210871 [TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of botulinum toxin A for treating neuropathic pain in patients with spinal cord injury. Li G; Lv CA; Tian L; Jin LJ; Sun P; Zhao W Medicine (Baltimore); 2017 May; 96(20):e6919. PubMed ID: 28514309 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous and perineural botulinum toxin type a for neuropathic pain: a descriptive review. Fabregat G; De Andrés J; Villanueva-Pérez VL; Asensio-Samper JM Clin J Pain; 2013 Nov; 29(11):1006-12. PubMed ID: 23370086 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Attal N; de Andrade DC; Adam F; Ranoux D; Teixeira MJ; Galhardoni R; Raicher I; Üçeyler N; Sommer C; Bouhassira D Lancet Neurol; 2016 May; 15(6):555-65. PubMed ID: 26947719 [TBL] [Abstract][Full Text] [Related]
8. Treatment of at-level spinal cord injury pain with botulinum toxin A. Chun A; Levy I; Yang A; Delgado A; Tsai CY; Leung E; Taylor K; Kolakowsky-Hayner S; Huang V; Escalon M; Bryce TN Spinal Cord Ser Cases; 2019; 5():77. PubMed ID: 31632735 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin a improved burning pain and allodynia in two patients with spinal cord pathology. Jabbari B; Maher N; Difazio MP Pain Med; 2003 Jun; 4(2):206-10. PubMed ID: 12873271 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia. Liu HT; Tsai SK; Kao MC; Hu JS Pain Med; 2006; 7(1):89-91. PubMed ID: 16533208 [TBL] [Abstract][Full Text] [Related]
11. [Botulinum toxin type A in the treatment of neuropathic pain in a case of postherpetic neuralgia]. Ruiz Huete C; Bermejo P Neurologia; 2008 May; 23(4):259-62. PubMed ID: 18516748 [TBL] [Abstract][Full Text] [Related]
12. Has botulinum toxin type A a place in the treatment of spasticity in spinal cord injury patients? Al-Khodairy AT; Gobelet C; Rossier AB Spinal Cord; 1998 Dec; 36(12):854-8. PubMed ID: 9881735 [TBL] [Abstract][Full Text] [Related]
13. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections. Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489 [TBL] [Abstract][Full Text] [Related]
14. [Subcutaneous botulinum toxin in the treatment of peripheral neuropathic pain]. Puentes Gutiérrez AB; García Bascones M; Puentes Gutiérrez R; Díaz Jiménez M Rehabilitacion (Madr); 2019; 53(2):131-135. PubMed ID: 31186096 [TBL] [Abstract][Full Text] [Related]
15. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia. Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121 [TBL] [Abstract][Full Text] [Related]
16. Single application of A2 NTX, a botulinum toxin A2 subunit, prevents chronic pain over long periods in both diabetic and spinal cord injury-induced neuropathic pain models. Ma L; Nagai J; Sekino Y; Goto Y; Nakahira S; Ueda H J Pharmacol Sci; 2012; 119(3):282-6. PubMed ID: 22785019 [TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury. Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin - neuropathic pain: Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Br Dent J; 2016 Aug; 221(3):126. PubMed ID: 27514345 [TBL] [Abstract][Full Text] [Related]
19. Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms. Ahn SH; Park HW; Lee BS; Moon HW; Jang SH; Sakong J; Bae JH Spine (Phila Pa 1976); 2003 Feb; 28(4):341-6; discussion 346-7. PubMed ID: 12590206 [TBL] [Abstract][Full Text] [Related]
20. Side effects of intradetrusor botulinum toxin injections on ejaculation and fertility in men with spinal cord injury: preliminary findings. Caremel R; Courtois F; Charvier K; Ruffion A; Journel NM BJU Int; 2012 Jun; 109(11):1698-702. PubMed ID: 21981647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]